{"id":912,"date":"2025-09-19T09:00:49","date_gmt":"2025-09-19T07:00:49","guid":{"rendered":"https:\/\/methysdx.com\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/"},"modified":"2025-11-01T02:42:26","modified_gmt":"2025-11-01T01:42:26","slug":"methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc","status":"publish","type":"post","link":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/","title":{"rendered":"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program !"},"content":{"rendered":"

19\/09\/2025 – METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program<\/a>. METHYS Dx is delighted to have been selected alongside 8 other innovative start-ups in the field of oncology!<\/p>\n

Congratulations to the other selected start-ups s\u00e9lectionn\u00e9es\u00a0 : BiPER Therapeutics<\/a>,\u00a0 CYBERNA<\/a>, \ud835\udddf\ud835\uddee\ud835\uddf3\ud835\uddee\ud835\uddfa\ud835\uddf2<\/a>, \ud835\udde1\ud835\uddee\ud835\uddfb\ud835\uddfc\ud835\uddde\ud835\ude02\ud835\uddff , Peekcell<\/a> , \ud835\udde6\ud835\uddfd\ud835\uddf6\ud835\uddf0\ud835\uddf2 \ud835\uddd5\ud835\uddf6\ud835\uddfc, Syntopia<\/a> and \ud835\udde7\ud835\uddee\ud835\ude01\ud835\ude02\ud835\uddfa \ud835\uddd5\ud835\uddf6\ud835\uddfc\ud835\ude00\ud835\uddf0\ud835\uddf6\ud835\uddf2\ud835\uddfb\ud835\uddf0\ud835\uddf2\ud835\ude00<\/a>.<\/strong><\/p>\n

We are very excited to embark on this journey and to benefit from the support of PSCC!<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

19\/09\/2025 – METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program. METHYS Dx is delighted to have been selected alongside 8 other innovative start-ups in the field of oncology! Congratulations to the other selected start-ups s\u00e9lectionn\u00e9es\u00a0 : BiPER Therapeutics,\u00a0 CYBERNA, \ud835\udddf\ud835\uddee\ud835\uddf3\ud835\uddee\ud835\uddfa\ud835\uddf2, \ud835\udde1\ud835\uddee\ud835\uddfb\ud835\uddfc\ud835\uddde\ud835\ude02\ud835\uddff , Peekcell , \ud835\udde6\ud835\uddfd\ud835\uddf6\ud835\uddf0\ud835\uddf2 \ud835\uddd5\ud835\uddf6\ud835\uddfc, Syntopia and […]<\/p>\n","protected":false},"author":2,"featured_media":892,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nMETHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program ! | Methys DX<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program ! | Methys DX\" \/>\n<meta property=\"og:description\" content=\"19\/09\/2025 – METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program. METHYS Dx is delighted to have been selected alongside 8 other innovative start-ups in the field of oncology! Congratulations to the other selected start-ups s\u00e9lectionn\u00e9es\u00a0 : BiPER Therapeutics,\u00a0 CYBERNA, \ud835\udddf\ud835\uddee\ud835\uddf3\ud835\uddee\ud835\uddfa\ud835\uddf2, \ud835\udde1\ud835\uddee\ud835\uddfb\ud835\uddfc\ud835\uddde\ud835\ude02\ud835\uddff , Peekcell , \ud835\udde6\ud835\uddfd\ud835\uddf6\ud835\uddf0\ud835\uddf2 \ud835\uddd5\ud835\uddf6\ud835\uddfc, Syntopia and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/\" \/>\n<meta property=\"og:site_name\" content=\"Methys DX\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T07:00:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-01T01:42:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/methysdx.com\/wp-content\/uploads\/2025\/11\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1146\" \/>\n\t<meta property=\"og:image:height\" content=\"1134\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin_methysDX\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_methysDX\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/\"},\"author\":{\"name\":\"admin_methysDX\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/#\\\/schema\\\/person\\\/507d5a166b1f06448364f9269baddc83\"},\"headline\":\"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program !\",\"datePublished\":\"2025-09-19T07:00:49+00:00\",\"dateModified\":\"2025-11-01T01:42:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/\"},\"wordCount\":81,\"image\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/\",\"url\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/\",\"name\":\"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program ! | Methys DX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png\",\"datePublished\":\"2025-09-19T07:00:49+00:00\",\"dateModified\":\"2025-11-01T01:42:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/#\\\/schema\\\/person\\\/507d5a166b1f06448364f9269baddc83\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png\",\"contentUrl\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png\",\"width\":1146,\"height\":1134},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/methysdx.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program !\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/#website\",\"url\":\"https:\\\/\\\/methysdx.com\\\/\",\"name\":\"Methys DX\",\"description\":\"D\u00e9tection de signatures mol\u00e9culaires uniques sp\u00e9cifiques de diff\u00e9rents cancers par PCR digitale\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/methysdx.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/#\\\/schema\\\/person\\\/507d5a166b1f06448364f9269baddc83\",\"name\":\"admin_methysDX\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g\",\"caption\":\"admin_methysDX\"},\"url\":\"https:\\\/\\\/methysdx.com\\\/en\\\/author\\\/admin_methysdx\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program ! | Methys DX","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/","og_locale":"en_US","og_type":"article","og_title":"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program ! | Methys DX","og_description":"19\/09\/2025 – METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program. METHYS Dx is delighted to have been selected alongside 8 other innovative start-ups in the field of oncology! Congratulations to the other selected start-ups s\u00e9lectionn\u00e9es\u00a0 : BiPER Therapeutics,\u00a0 CYBERNA, \ud835\udddf\ud835\uddee\ud835\uddf3\ud835\uddee\ud835\uddfa\ud835\uddf2, \ud835\udde1\ud835\uddee\ud835\uddfb\ud835\uddfc\ud835\uddde\ud835\ude02\ud835\uddff , Peekcell , \ud835\udde6\ud835\uddfd\ud835\uddf6\ud835\uddf0\ud835\uddf2 \ud835\uddd5\ud835\uddf6\ud835\uddfc, Syntopia and […]","og_url":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/","og_site_name":"Methys DX","article_published_time":"2025-09-19T07:00:49+00:00","article_modified_time":"2025-11-01T01:42:26+00:00","og_image":[{"width":1146,"height":1134,"url":"https:\/\/methysdx.com\/wp-content\/uploads\/2025\/11\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png","type":"image\/png"}],"author":"admin_methysDX","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_methysDX","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#article","isPartOf":{"@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/"},"author":{"name":"admin_methysDX","@id":"https:\/\/methysdx.com\/#\/schema\/person\/507d5a166b1f06448364f9269baddc83"},"headline":"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program !","datePublished":"2025-09-19T07:00:49+00:00","dateModified":"2025-11-01T01:42:26+00:00","mainEntityOfPage":{"@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/"},"wordCount":81,"image":{"@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#primaryimage"},"thumbnailUrl":"https:\/\/methysdx.com\/wp-content\/uploads\/2025\/11\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/","url":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/","name":"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program ! | Methys DX","isPartOf":{"@id":"https:\/\/methysdx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#primaryimage"},"image":{"@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#primaryimage"},"thumbnailUrl":"https:\/\/methysdx.com\/wp-content\/uploads\/2025\/11\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png","datePublished":"2025-09-19T07:00:49+00:00","dateModified":"2025-11-01T01:42:26+00:00","author":{"@id":"https:\/\/methysdx.com\/#\/schema\/person\/507d5a166b1f06448364f9269baddc83"},"breadcrumb":{"@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#primaryimage","url":"https:\/\/methysdx.com\/wp-content\/uploads\/2025\/11\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png","contentUrl":"https:\/\/methysdx.com\/wp-content\/uploads\/2025\/11\/Capture-de\u0301cran-2025-10-31-a\u0300-17.48.49.png","width":1146,"height":1134},{"@type":"BreadcrumbList","@id":"https:\/\/methysdx.com\/en\/methys-dx-a-ete-selectionnee-pour-rejoindre-le-programme-boost-du-paris-saclay-cancer-cluster-pscc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/methysdx.com\/en\/"},{"@type":"ListItem","position":2,"name":"METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program !"}]},{"@type":"WebSite","@id":"https:\/\/methysdx.com\/#website","url":"https:\/\/methysdx.com\/","name":"Methys DX","description":"D\u00e9tection de signatures mol\u00e9culaires uniques sp\u00e9cifiques de diff\u00e9rents cancers par PCR digitale","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/methysdx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/methysdx.com\/#\/schema\/person\/507d5a166b1f06448364f9269baddc83","name":"admin_methysDX","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g","caption":"admin_methysDX"},"url":"https:\/\/methysdx.com\/en\/author\/admin_methysdx\/"}]}},"_links":{"self":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts\/912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/comments?post=912"}],"version-history":[{"count":2,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts\/912\/revisions"}],"predecessor-version":[{"id":914,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts\/912\/revisions\/914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/media\/892"}],"wp:attachment":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/media?parent=912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/categories?post=912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/tags?post=912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}